-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexicon Pharmaceuticals Announces Ongoing FDA Review for Zynquista NDA Resubmission with Additional Data from Multiple Investigator-Sponsored Trials

Reuters·09/22/2025 20:00:13

Please log in to view news